MedCap AB (OSTO:MCAP) Cyclically Adjusted FCF per Share: kr9.19 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MCAP MedCap AB OSTO:MCAP
95 GF Score
Price kr568.50
GF Value kr572.85
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is MedCap AB Cyclically Adjusted FCF per Share?

MedCap AB OSTO:MCAP +3.27% 95 Cyclically Adjusted FCF per Share is kr9.19 as of Jun. 2026. GuruFocus rates OSTO:MCAP with a GF Score™ of 95/100 and a GF Value™ of kr572.85 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MedCap AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr7.192. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr9.19 for the trailing ten years ended in Jun. 2026.

During the past 12 months, MedCap AB's average Cyclically Adjusted FCF Growth Rate was 37.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 50.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 33.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of MedCap AB was 50.90% per year. The lowest was 14.30% per year. And the median was 20.40% per year.

As of today (2026-08-31), MedCap AB's current stock price is kr568.50. MedCap AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr9.19. MedCap AB's Cyclically Adjusted Price-to-FCF of today is 61.86.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MedCap AB was 147.07. The lowest was 54.46. And the median was 93.78.


MedCap AB  (OSTO:MCAP) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

MedCap AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=568.50/9.19
=61.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MedCap AB was 147.07. The lowest was 54.46. And the median was 93.78.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MedCap AB Cyclically Adjusted FCF per Share Related Terms


MedCap AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for MedCap AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB Cyclically Adjusted FCF per Share Chart

MedCap AB Annual Data
Trend Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.11 2.24 3.12 5.40 7.69

MedCap AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.71 6.79 7.69 8.27 9.19

OSTO:MCAP vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, MedCap AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MedCap AB's Cyclically Adjusted Price-to-FCF falls into.


OSTO:MCAP
95GF Score
MedCap AB OSTO:MCAP
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedCap AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedCap AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=7.192/134.6100*134.6100
=7.192

Current CPI (Jun. 2026) = 134.6100.

MedCap AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201607 -0.257 101.080 -0.342
201610 0.338 101.485 0.448
201701 2.151 101.326 2.858
201704 1.035 102.615 1.358
201707 -0.017 103.301 -0.022
201710 0.555 103.202 0.724
201803 1.311 103.962 1.697
201806 -0.239 104.875 -0.307
201809 -0.052 105.679 -0.066
201812 3.198 105.912 4.065
201903 1.866 105.886 2.372
201906 0.216 106.742 0.272
201909 0.676 107.214 0.849
201912 0.297 107.766 0.371
202003 1.605 106.563 2.027
202006 2.870 107.498 3.594
202009 -0.196 107.635 -0.245
202012 2.121 108.296 2.636
202103 0.682 108.360 0.847
202106 1.412 108.928 1.745
202109 1.006 110.338 1.227
202112 0.642 112.486 0.768
202203 2.641 114.825 3.096
202206 1.027 118.384 1.168
202209 2.465 122.296 2.713
202212 -3.343 126.365 -3.561
202303 3.001 127.042 3.180
202306 1.998 129.407 2.078
202309 3.506 130.224 3.624
202312 4.197 131.912 4.283
202403 4.985 132.205 5.076
202406 3.661 132.716 3.713
202409 3.951 132.304 4.020
202412 7.078 132.987 7.164
202503 2.752 132.825 2.789
202506 4.072 133.699 4.100
202509 3.360 133.480 3.388
202512 8.511 133.390 8.589
202603 2.357 133.560 2.376
202606 7.192 134.610 7.192

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr9.19 mean?
MedCap AB (OSTO:MCAP) has a Cyclically Adjusted FCF per Share of kr9.19 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MedCap AB and its competitors.
Is MedCap AB's Cyclically Adjusted FCF per Share too high?
MedCap AB's current Cyclically Adjusted FCF per Share is kr9.19. Overall, MedCap AB has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
MedCap AB's Cyclically Adjusted FCF per Share of kr9.19 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MedCap AB and its competitors. MedCap AB's current Cyclically Adjusted FCF per Share is kr9.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr572.85, compared to a current price of kr568.50 — trading 0.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr9.19. MedCap AB's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current Cyclically Adjusted FCF per Share is kr9.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedCap AB (OSTO:MCAP) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of kr568.50 is trading 0.8% below its estimated GF Value™ of kr572.85. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for OSTO:MCAP:

  • Cyclically Adjusted FCF per Share: kr9.19
  • GF Value™: kr572.85 vs. price of kr568.50 (0.8% below fair value)
  • GF Score™: 95/100 with 1 warning sign

No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedCap AB Business Description

Other Exchanges MCAPs:UK61MA:Germany
Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
95GF Score

Get the complete analysis for OSTO:MCAP

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr568.50
Price
kr572.85
GF Value